It is recognized that hypercholesterolemia in man plays a significant role in predisposing individuals to premature clinical coronary artery disease. This correlation has stimulated much research into determining the genetic and environmental causes of hypercholesterolemia. Our studies of cells cultured from normal individuals and patients with abnormalities of cholesterol metabolism offer a direct method for examining the regulatory events involved in these human disease processes at the cellular level. The laboratory and clinical facilities that we have established, at Children's Hospital, Boston, to study inborn errors of lipid metabolism, provides access to a wide variety of children with these disorders from whom cell cultures may be established for study. In recent studies, we have discovered a new biochemical condition mimicing homozygous familial hypercholesterolemia, which may provide new insight into the regulation of cholesterol metabolism in man. In addition, our studies of the human fibroblast enzyme acid lipase will be continued utilizing the new sensitive assay system that we have developed. The fibroblast system will be used to study the regulation of acid lipase activity and to investigate the possible role of this enzyme in atherogenesis. We also propose studies on primary rat hepatocyte cultures to examine in detail the regulation of cholesterol biosynthesis by a cell type which governs a major portion of the synthetic and regulatory events of cholesterol metabolism in the intact animal. Techniques have only recently been available for the establishment of homogeneous non-proliferating monolayer cultures of adult rat hepatic parenchymal cells. This system is viable for a long enough period in vitro to study the mechanisms involved in the direct effects on liver cells of normocholesterolemic, hypercholesterolemic, and intestinal lymph lipoproteins. At the same time as rat liver cultures are being examined, rat fibroblasts will be compared in parallel studies to determine if regulation is similar in these two different cells from the same animal. Since rats are widely utilized for studies of cholesterol metabolism, it will be of interest to determine if the regulatory events seen in rat fibroblasts are similar to those in human fibroblasts. This combined approach of studies utilizing cultured normal and abnormal human cells as well as animal cells offers a useful method of obtaining information about the events which are intimately involved in the human arteriosclerotic disease process.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033714-03
Application #
3345837
Study Section
(STC)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
Graduate Schools
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Liu, Simin; Song, Yiqing; Hu, Frank B et al. (2004) A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men. Atherosclerosis 177:119-26
Liu, Simin; Ma, Jing; Ridker, Paul M et al. (2003) A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men. Atherosclerosis 166:323-9
Trogan, Eugene; Choudhury, Robin P; Dansky, Hayes M et al. (2002) Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 99:2234-9
Han, Zhihua; Heath, Simon C; Shmulewitz, Dvora et al. (2002) Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Am J Med Genet 110:234-42
Rong, J X; Li, J; Reis, E D et al. (2001) Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation 104:2447-52
Tamminen, M; Mottino, G; Qiao, J H et al. (1999) Ultrastructure of early lipid accumulation in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19:847-53
Dansky, H M; Charlton, S A; Barlow, C B et al. (1999) Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium. J Clin Invest 104:31-9
Weng, W; Brandenburg, N A; Zhong, S et al. (1999) ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice. J Lipid Res 40:1064-70
Zaiou, M; Azrolan, N; Hayek, T et al. (1998) The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1. J Clin Invest 101:1699-707
Weng, W; Breslow, J L (1996) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci U S A 93:14788-94

Showing the most recent 10 out of 73 publications